Pharmacokinetics is the study of how the human body affects a specific drug over a period of time. This dynamic process is divided into four primary stages, commonly remembered by the acronym ADME: absorption, distribution, metabolism, and excretion. When a nurse administers a medication in a Nigerian hospital ward, the drug immediately begins interacting with various biological systems. Understanding these four stages helps clinicians anticipate when a drug will start working, how long it will remain active, and when it leaves the body. Without this foundation, predicting therapeutic responses or managing accidental overdoses becomes nearly impossible.
Absorption is the movement of a drug from its site of administration into the central bloodstream. The rate and extent of absorption depend heavily on the route of administration, blood supply to the area, and the chemical properties of the drug.
Once a drug enters the bloodstream, it distributes into interstitial and intracellular fluid compartments. Blood flow to organs dictates the speed of distribution; highly perfused organs like the brain, heart, and liver receive the drug much faster than adipose tissue or skin. Plasma protein binding also plays a massive role. Drugs bound to albumin are too large to slip through capillary walls and remain inactive in the blood until they dissociate. Only the free, unbound fraction of a drug can bind to target receptors and exert a pharmacological effect.
Biotransformation transforms lipophilic drug molecules into more water-soluble compounds so the kidneys can easily eliminate them. The liver is the principal site for this activity, driven largely by the cytochrome P450 enzyme system.
Excretion removes drugs and their metabolites permanently from the body. The kidneys handle the lion's share of this task through glomerular filtration, active tubular secretion, and passive tubular reabsorption. However, extra-renal routes matter too. Volatile anesthetic gases leave the body through the lungs, while certain drugs and heavy metals are excreted via bile into the feces, or eliminated in sweat, tears, and breast milk. Nurses must monitor renal function labs, such as serum creatinine and estimated glomerular filtration rate, before administering drugs cleared primarily by the kidneys.
Two key numerical values dictate dosing schedules: half-life and clearance. Half-life is the time required for the plasma concentration of a drug to decrease by fifty percent. Drugs with short half-lives require frequent dosing to maintain steady therapeutic levels, whereas long half-life drugs can be given once daily or less. Clearance measures the volume of plasma completely cleared of a drug per unit of time. Together, these metrics guide healthcare teams in tailoring safe and effective medication regimens for individual patients.
Bioavailability measures the fraction of an administered dose that reaches systemic circulation unchanged. Intravenous injections boast a bioavailability of one hundred percent because they bypass absorption barriers entirely. Oral medications often feature lower bioavailability due to incomplete gut absorption and first-pass metabolism. When repetitive doses are given at regular intervals, drug accumulation reaches a plateau known as steady-state concentration, where the rate of drug administration equals the rate of elimination.
Applying pharmacokinetics at the bedside bridges basic science with patient safety. Nurses must assess factors like age, renal function, liver health, and concurrent drug therapies that alter pharmacokinetic profiles. Elderly patients often experience slower drug clearance and reduced metabolic capacity, requiring lower doses to prevent adverse drug reactions. Monitoring peak and trough levels for medications with narrow therapeutic indices ensures treatments remain both safe and effective during hospitalization.